Black Hawk Acquisition - Class A (BKHA) closed at $6.48 on November 19, 2026, down 24.7% from the previous close, on volume of 17,470 shares (30-day average 138,739).
Data as of November 19, 2026.
No headlines found.
Vesicor Therapeutics and Black Hawk Acquisition Corporation Announce Closing of Business Combination
Globe Newswire (Fri, 20-Nov 8:00 AM ET)
Black Hawk Acquisition Corp is a Blank check company.
Black Hawk Acquisition - Class A trades on the NASDAQ stock market under the symbol BKHA.
As of November 20, 2026, BKHA stock price declined to $1.85 with 1,006,332 million shares trading.
BKHA has a beta of 1.35, meaning it tends to be more sensitive to market movements. BKHA has a correlation of 0.05 to the broad based SPY ETF.
BKHA has a market cap of $7.68 million. This is considered a Sub-Micro Cap stock.
BKHA has underperformed the market in the last year with a price return of -83.5% while the SPY ETF gained +5.3%. BKHA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -84.4% and -58.9%, respectively, while the SPY returned -10.0% and -5.8%, respectively.
BKHA support price is $5.64 and resistance is $7.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BKHA shares will trade within this expected range on the day.